Table 1.
Characteristics of children enrolled in 2018/19 season (n = 4243)*.
Fig 1.
Number of patients tested by rapid influenza diagnostic tests by week in the column chart (n = 4243).
Epidemic curves for A(H1N1)pdm09 and A(H3N2) by the World Health Organization in the line graph [16].
Table 2.
Adjusted vaccine effectiveness (VE) of quadrivalent inactivated influenza vaccine for preventing influenza in the 2018/19 season (n = 4243).
VE for preventing influenza A (N = 4243).
Table 3.
Adjusted vaccine effectiveness (VE) of quadrivalent inactivated influenza vaccine for preventing influenza in the 2018/19 season (n = 4243).
Adjusted vaccine effectiveness (VE) of quadrivalent inactivated influenza vaccine for preventing influenza A(H1N1)pdm09 and A(H3N2) in 3 hospitals that used rapid influenza diagnostic test kits for detecting A(H1N1)pdm09 (N = 238).
Table 4.
Adjusted vaccine effectiveness (VE) of quadrivalent inactivated influenza vaccine for preventing influenza hospitalization in the 2018/19 season.
Table 5.
Adjusted vaccine effectiveness (VE) of quadrivalent inactivated influenza vaccine by vaccine dose for preventing influenza illness among children in the 2018/19 season.
Number of enrollees.
Table 6.
Adjusted vaccine effectiveness (VE) of quadrivalent inactivated influenza vaccine by vaccine dose for preventing influenza illness among children in the 2018/19 season.
Adjusted vaccine effectiveness (VE) against influenza A by vaccine dose.